Cronos Group posts 40% revenue growth in Q1 2026, hitting record profits and market leadership in Canadian vapes.

Cronos Group reported a 40% year-over-year increase in net revenue to $45.2 million for Q1 2026, driven by strong sales in Israel and Canada. The company achieved record gross profit and secured the #1 market share in Canadian vape products with its Spinach® brand. Cronos also expanded internationally, with significant growth in Israel's medical cannabis market and other countries, and is set to acquire Dutch producer CanAdelaar to strengthen its European presence. Backed by a robust balance sheet with $822 million in cash, Cronos plans to continue investing in growth and innovation across its global cannabis portfolio.